Mylan CEO To Appear At Forbes Health Summit But Won't Testify at Grassley's Hearing

Mylan CEO Heather Bresch will address the EpiPen pricing uproar at Forbes Health Summit Dec. 1, though she refused to testify before the Senate Judiciary Committee at a now-canceled Nov. 30 Senate hearing. Sen. Charles Grassley (R-IA) urged her to appear before the committee, but Bresch refused. CMS and the U.S. Department of Justice also declined to send officials to testify. In a statement sent to STAT's Pharmalot blog, Grassley said the billions of dollars spent on drugs oblige pharmaceutical...